NCT03237078 Lactobacillus Plantarum PS128 in Patients With Major Depressive Disorder and High Level of Inflammation Status UNKNOWN Phase NA
NCT03230682 Eealy Improvement Predicts Antidepressants Response in Adults With Major Depression Disorder Status UNKNOWN Phase N/A
NCT03222752 Efficacy of Cranial Electrotherapy Stimulation (CES) for the Treatment of Major Depressive Disorder Status TERMINATED Phase NA
NCT03202095 Creatine for Treatment of Depression Associated With Type 2 Diabetes Status WITHDRAWN Phase PHASE4
NCT03193398 BTRX-246040 Administered Once Daily to Patients With Major Depressive Disorder Status COMPLETED Phase PHASE2
NCT03191994 Impact of an Eight Week Exercise Intervention in Treating Major Depressive Disorder Status UNKNOWN Phase NA
NCT03188185 A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD) Status COMPLETED Phase PHASE3
NCT03183505 Comparison of Anyu Peibo With Placebo in Treatment of MDD,Ⅱb Status COMPLETED Phase PHASE2
NCT03175068 Transdiagnostic Brain-Behavior Profiling to Enhance Cognitive Behavioral Therapy Response Status UNKNOWN Phase NA
NCT03163940 Laughter Yoga Intervention for People With Major Depressive Disorder Status COMPLETED Phase NA
NCT03156556 Improving Access to the Treatment of Anxiety and Depression Among Young Adults Status COMPLETED Phase NA
NCT03143075 Do Omega-3 Fatty Acids Have an Antidepressant Effect in Patients With Signs of Peripheral Inflammation? Status COMPLETED Phase NA